Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Matrix Biology : Journal of the International Society for Matrix Biology|December 31, 2013
Biglycan modulates angiogenesis and bone formation during fracture healingAgnes D Berendsen, Emily L Pinnow, Azusa Maeda, et al.
Plos Pathogens|September 25, 2025
In vivo and in vitro recombinant systems of a novel variant demonstrate cross-reactive neutralization for the HCV model virus, Norway rat hepacivirusCaroline E Thorselius, Andreas Kok, Raphael Wolfisberg, et al.
Science Advances|May 29, 2026
Hepatitis C virus infection dynamics, treatment, and lipid nanoparticle-mediated infection in humanized liver chimeric mouse modelsSeung Bum Park, Jaime Sánchez-Meza, Regina Umarova, et al.
The Journal of Experimental Medicine|September 9, 2005
MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cellsSergey Filippov, Gerald C Koenig, Tae-Hwa Chun, et al.
The Journal of Biological Chemistry|April 13, 2015
WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt SignalingAzusa Maeda, Mitsuaki Ono, Kenn Holmbeck, et al.
The Journal of Cell Biology|April 2, 2003
uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesionLars H Engelholm, Karin List, Sarah Netzel-Arnett, et al.
Scientific Reports|August 31, 2016
Decreased demand for olfactory periglomerular cells impacts on neural precursor cell viability in the rostral migratory streamAnika Langenfurth, Song Gu, Verena Bautze, et al.
The Journal of Cell Biology|September 11, 2013
M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathwayDaniel H Madsen, Daniel Leonard, Andrius Masedunskas, et al.
Scientific Reports|July 24, 2024
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animalsAnna Offersgaard, Carlos R Duarte Hernandez, Yuyong Zhou, et al.
Ebiomedicine|February 21, 2025
Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infectionKatharina Wørzner, Signe Tandrup Schmidt, Julie Zimmermann, et al.
Pageof 7